Evidence map›Paper›PMID 26733354›Full record

ArticleScientific reports2016

PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.

Mei-Ling Kuo, Mabel Bin-Er Lee, Michelle Tang, Willem den Besten, Shuya Hu, Michael J Sweredoski, Sonja Hess, Chih-Ming Chou, Chun A Changou, Mingming Su and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. In Vitro Cytotoxic Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Hatching is modulated by microRNA-378a-3p derived from extracellular vesicles secreted by blastocysts.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Mei-Ling KuoDepartment of Molecular Pharmacology, Beckman Research Institute at City of Hope, Duarte, CA 91010, USA.
Mabel Bin-Er LeeDepartment of Molecular Pharmacology, Beckman Research Institute at City of Hope, Duarte, CA 91010, USA.
Michelle TangDepartment of Molecular Pharmacology, Beckman Research Institute at City of Hope, Duarte, CA 91010, USA.
Willem den BestenDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Shuya HuDepartment of Molecular Pharmacology, Beckman Research Institute at City of Hope, Duarte, CA 91010, USA.
Michael J SweredoskiProteome Exploration Laboratory, Division of Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, CA, 91125.
Sonja HessProteome Exploration Laboratory, Division of Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, CA, 91125.
Chih-Ming ChouDepartment of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 110.
Chun A ChangouIntegrated Laboratory, Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan 110.
Mingming SuUniversity of Hawaii Cancer Center, HI 96813, USA.
Wei JiaUniversity of Hawaii Cancer Center, HI 96813, USA.
Leila SuGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan 110.
Yun YenDepartment of Molecular Pharmacology, Beckman Research Institute at City of Hope, Duarte, CA 91010, USA.
Beckman Research InstituteCalifornia Institute of Technology · USTaipei Medical University · TWUniversity of Hawaii Cancer CenterUniversity of Hawaii System · US

Funding

University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GERTRAUD MASKARINEC · 1996 to 2026
$56.2M
Drug Development of Ribonucleotide Reductase InhibitorR01CA127541 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI HORNE, DAVID A. · 2008 to 2012
$1.7M
NCI NIH HHS 5R01CA127541NCI NIH HHS P30 CA071789NCI NIH HHS R01 CA127541
6 · The paper itself

Abstract

Ribonucleotide reductase small subunit B (RRM2B) is a stress response protein that protects normal human fibroblasts from oxidative stress. However, the underlying mechanism that governs this function is not entirely understood. To identify factors that interact with RRM2B and mediate anti-oxidation function, large-scale purification of human Flag-tagged RRM2B complexes was performed. Pyrroline-5-carboxylate reductase 1 and 2 (PYCR1, PYCR2) were identified by mass spectrometry analysis as components of RRM2B complexes. Silencing of both PYCR1 and PYCR2 by expressing short hairpin RNAs induced defects in cell proliferation, partial fragmentation of the mitochondrial network, and hypersensitivity to oxidative stress in hTERT-immortalized human foreskin fibroblasts (HFF-hTERT). Moderate overexpression of RRM2B, comparable to stress-induced level, protected cells from oxidative stress. Silencing of both PYCR1 and PYCR2 completely abolished anti-oxidation activity of RRM2B, demonstrating a functional collaboration of these metabolic enzymes in response to oxidative stress.

Indexed as

Oxidative StressAnimalsAntioxidantsCell Cycle CheckpointsCell Cycle ProteinsCell Linedelta-1-Pyrroline-5-Carboxylate ReductaseGene Knockdown TechniquesGene SilencingHumansIsoenzymesMass SpectrometryMitochondriaMultiprotein ComplexesProtein BindingProtein Interaction MappingAntioxidantsCell Cycle Proteinsdelta-1-Pyrroline-5-Carboxylate ReductaseIsoenzymesMultiprotein ComplexesPyrroline Carboxylate ReductasesRecombinant Fusion ProteinsRibonucleotide ReductasesRRM2B protein, humanTelomeraseTumor Suppressor Protein p53

Identifiers

PMID26733354
PMCPMC4702135
OpenAlexW2230463780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.